Pharmacy

Image description

J&J acquires Alios BioPharma for $1.8 billion

Johnson & Johnson on Tuesday announced a definitive agreement to acquire Alios BioPharma, a privately held clinical stage biopharmaceutical company focused on developing therapies for viral diseases, for approximately $1.8 billion in cash.